Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Steve Fein"'
Autor:
Umberto Veronesi, Edith A. Perez, Judy Garber, Stefan Glück, James J. Vredenburgh, Eric Winer, Gabriel N. Hortobagyi, Hyman B. Muss, Carolyn Sartor, Eva Rubin, Rayna Kneuper Hall, Roland Holland, Veronique Cocquyt, Giovanni Rosti, Giammaria Fiorentini, Phillip Nicholas Blondeel, Eli Avisar, P. Murali Doraiswamy, Judith Hurley, Amy Pickar Abernethy, Jennie R. Crews, Merce Jorda, Maria Victoria Velasquez, Monica Maria Yepes, Anna Maria Gonzalez Angulo, Charles L. Bennett, Cristiane Takita, Mohamed A Kharfan-Dabaja, Daniel Morgensztern, Deborah O. Heros, Eloy Roman, Lawrence Negret, Gilberto Lopes, Manuel F. Rosado, Steve Fein, Teresa De Cesare, Sakher Abdullah, Ernesto Ayala, Orfirio M. Sanchez, Carlos Silva, Ervin Gonzalez, Jason Brenner, Jorge E. Silva, Humberto Caldera, Swami Padmanabhan, Susan Moreno, Alicia Ceballos, Talia Donenberg, Susanna Quasem, Kristi L. Lenz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca335a9778ba723b70f2690a56016e21
https://doi.org/10.1016/b978-3-437-24260-1.50006-3
https://doi.org/10.1016/b978-3-437-24260-1.50006-3
Publikováno v:
Journal of clinical gastroenterology. 40(10)
Goals: The objective of our investigation was to examine the clinical utilization of digital rectal examination (DRE) and fecal occult blood testing (FOBT) at hospital admission. Background: DRE at the time of hospital admission is frequently accompa
Autor:
Harold Bien, Steve Fein, Frederique Rattis, Erev Tubb, Eduardo M. Sotomayor, Hyam I. Levitsky, Ivan Borrello, Zhengbin Lu, Stephen P. Schoenberger
Publikováno v:
Nature medicine. 5(7)
Tumor antigen-specific T-cell tolerance limits the efficacy of therapeutic cancer vaccines. Antigen-presenting cells mediate the induction of T-cell tolerance to self-antigens. We therefore assessed the fate of tumor-specific CD4+ T cells in tumor-be
Autor:
Drew M. Pardoll, Kevin Staveley-O'Carroll, Leon Hwang, Jami Montgomery, Hyam I. Levitsky, Eduardo M. Sotomayor, Steve Fein, Ivan Borrello
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America. 95(3)
The priming of tumor-antigen-specific T cells is critical for the initiation of successful anti-tumor immune responses, yet the fate of such cells during tumor progression is unknown. Naive CD4+T cells specific for an antigen expressed by tumor cells
Autor:
Eugene R. Ahn, Yeon S. Ahn, Carlos J. Bidot, Garcia Martha, Steve Fein, Jy Wenche, Lander Gabriella
Publikováno v:
Blood. 104:3024-3024
INTRODUCTION. Rituximab, a chimeric monoclonal antibody against CD20 expressed on B cells, has been approved for the treatment of B cell neoplasms. Recently, studies have supported the use of rituximab in various autoimmune disorders such as systemic